Opportunities And Challenges In Drug Monitoring
BMI View : Growth in the number of mobile phone users and wireless subscribers, and advances in the innovative application of communication technology to address health priorities have the potential to transform the delivery of healthcare across the world. This provides significant opportunities for companies looking to invest in the telecare sector, including drug companies, insurance providers, mobile operators and software vendors.
BMI defines telecare as the use of mobile and internet technology to provide clinical care and non-clinical services, such as health education, disease surveillance and drug monitoring. It is our view that the continued growth in the demand for healthcare, the sustained growth in mobile and broadband subscribers, and the growing sophistication of communications network infrastructure is driving new opportunities in telecare across the globe.
Focusing on emerging markets, governments are adopting telecare as a complementary strategy to strengthen healthcare systems - telecare increases populations' access to healthcare, which continues to be a major issue. Here we identify investment opportunities in drug monitoring, a type of telecare particularly suited to the characteristics of emerging markets, using Kenya as a case study.
|Aiding Healthcare Delivery|
|Kenya: Cellular, 3G & 4G Mobile Phone Subscribers|